Your browser doesn't support javascript.
loading
The landscape of tyrosine kinase inhibitors in sarcomas: looking beyond pazopanib.
Wilding, Christopher P; Elms, Mark L; Judson, Ian; Tan, Aik-Choon; Jones, Robin L; Huang, Paul H.
Afiliação
  • Wilding CP; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Elms ML; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Judson I; Department of Medical Oncology, Sarcoma Unit, The Royal Marsden Hospital, London, UK.
  • Tan AC; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.
  • Jones RL; Department of Medical Oncology, Sarcoma Unit, The Royal Marsden Hospital, London, UK.
  • Huang PH; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
Expert Rev Anticancer Ther ; 19(11): 971-991, 2019 11.
Article em En | MEDLINE | ID: mdl-31665941
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Sarcoma / Sulfonamidas / Inibidores de Proteínas Quinases Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Sarcoma / Sulfonamidas / Inibidores de Proteínas Quinases Idioma: En Ano de publicação: 2019 Tipo de documento: Article